Blogs

Categories

Select a sub-category to view results

Films and Coatings
Pharmaceutical Packaging Components
Prefillable Systems
Self Injection Devices
Vial Containment Solutions
Washing and Sterilization
Reconstitution and Transfer Systems

Select a sub-category to view results

Analytical Lab Services
Contract Manufacturing
Fill-Finish
Regulatory Support

Select a sub-category to view results

Cell and Gene Therapy Packaging
Drug Development Process
Regulatory Challenges
Transitioning to Combination Products

Select a sub-category to view results

Corporate Development
ESG/Sustainability
One West Team (Employee Culture)
Our Culture of Giving (Philanthropy)
Research and Development

Previous Blogs

By Daniel Bantz

四月 28, 2017

It is imperative for the pharmaceutical industry to be prepared to comply with new compendia chapters as soon as they are enacted.  This comprises knowing of proposed changes as soon as announced, and being well prepared to accommodate them.  Expected to be implemented by late 2018 – the functionality tests section of USP Chapter <381> (Elastomeric Closure for Injections) will be removed, and greatly expanded functionality tests will be incorporated in new USP Chapter <382> (projected title: Elastomeric Closure Functionality in Injectable Pharmaceutical Packaging/Delivery Systems).